df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.6 KiB
5.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. | Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. | us/states/tx | Texas Legislature | 88 | SB 241 | Texas SB 241 (88) |
|
|
enacted |
|
5 | 52 | 4 | 2022-11-16 | 2023-05-27 | openstates | ocd-bill/ffa1eb26-44d6-4464-981a-b5de5e46923f | ftp://ftp.legis.state.tx.us/bills/88R/billhistory/senate_bills/SB00200_SB00299/SB 241.xml | 00c347621502d15dd41d773d66de5e8dae5c6bb9e6b6d08a2b065529ad656de5 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Texas SB 241 (88) — Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Engrossed (committee substitute) — source
- House Committee Report (committee substitute) — source
- Senate Committee Report (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- passage — 139–1 (pass) · lower
- passage — 0–0 (pass) · upper
- Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 241 be placed on its third reading and final passage. — 31–0 (pass) · upper
- passage — 0–0 (pass) · upper
Sponsors
- Perry — primary (person)
- Talarico — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-11-16 Received by the Secretary of the Senate
filing, introduction - 2022-11-16 Filed
filing - 2023-02-15 Read first time
introduction, reading-1 - 2023-02-15 Referred to Health & Human Services
referral-committee - 2023-03-08 Scheduled for public hearing on . . .
- 2023-03-08 No action taken in committee
- 2023-03-15 Scheduled for public hearing on . . .
- 2023-03-15 Considered in public hearing
- 2023-03-15 Testimony taken in committee
- 2023-03-15 Vote taken in committee
- 2023-03-20 Reported favorably as substituted
committee-passage-favorable - 2023-03-20 Recommended for local & uncontested calendar
- 2023-03-20 Committee report printed and distributed
- 2023-03-22 Placed on intent calendar
- 2023-03-23 Rules suspended-Regular order of business
- 2023-03-23 Read 2nd time
reading-2 - 2023-03-23 Amendment(s) offered
amendment-introduction - 2023-03-23 Amended
amendment-passage - 2023-03-23 Vote recorded in Journal
- 2023-03-23 Passed to engrossment as amended
amendment-passage - 2023-03-23 Vote recorded in Journal
- 2023-03-23 Three day rule suspended
- 2023-03-23 Record vote
- 2023-03-23 Read 3rd time
reading-3 - 2023-03-23 Passed
passage - 2023-03-23 Record vote
- 2023-03-23 Reported engrossed
- 2023-03-27 Received from the Senate
introduction - 2023-04-10 Read first time
introduction, reading-1 - 2023-04-10 Referred to Public Health
referral-committee - 2023-05-03 Considered in formal meeting
- 2023-05-03 Recommended to be sent to Local & Consent
referral-committee - 2023-05-03 Reported favorably w/o amendment(s)
committee-passage, committee-passage-favorable - 2023-05-06 Comte report filed with Committee Coordinator
filing - 2023-05-07 Committee report distributed
- 2023-05-08 Comm. report sent to Local & Consent Calendar
- 2023-05-10 Considered in Local & Consent Calendars
- 2023-05-12 Placed on Local, Consent, and Res. Calendar
- 2023-05-12 Read 2nd time
reading-2 - 2023-05-12 Passed to 3rd reading
- 2023-05-12 Nonrecord vote recorded in Journal
- 2023-05-12 Read 3rd time
reading-3 - 2023-05-12 Passed
passage - 2023-05-12 Record vote
- 2023-05-12 Nonrecord vote recorded in Journal
- 2023-05-15 House passage reported
passage - 2023-05-15 Reported enrolled
enrolled - 2023-05-16 Signed in the Senate
passage - 2023-05-16 Signed in the House
passage - 2023-05-16 Sent to the Governor
executive-receipt - 2023-05-27 Signed by the Governor
executive-signature - 2023-05-27 Effective on . . . . . . . . . . . . . . .
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ffa1eb26-44d6-4464-981a-b5de5e46923f. Confidence: reported (aggregated from official Texas legislature records).